GS-1427 / Gilead  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GS-1427 / Gilead
ACTRN12621000612819p: A Phase 1, Dose-Escalation Study in Healthy Volunteers to Evaluate the Pharmacokinetics, Safety, and Tolerability of GS-1427 Following Single and Multiple Dosing

Not yet recruiting
1
110
 
Gilead Sciences, Gilead Sciences
Inflammatory bowel disease
 
 
ACTRN12621000612819: A Phase 1, Dose-Escalation Study in Healthy Volunteers to Evaluate the Pharmacokinetics, Safety, and Tolerability of GS-1427 Following Single and Multiple Dosing

Completed
1
110
 
Gilead Sciences, Gilead Sciences
Inflammatory bowel disease
 
 

Download Options